Injectable Drug Delivery Market - Global Industry Analysis

Injectable Drug Delivery Market by Type (Formulation and Devices), by Application (Autoimmune Diseases, Oncology Disorders, Hormonal Disorders, Orphan Diseases, and Others), and by End-User (Hospital, Home Care, Ambulatory Care, Physician Offices or Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 05-Mar-2019 Category: Pharmaceutical Report Format : PDF Pages: 120 Report Code: ZMR-213 Status : Published

Global injectable drug delivery market expected to generate around USD 932.3 billion by 2025, at a CAGR of 11.2% between 2019 and 2025. The global injectable drug delivery market is anticipated to grow at a considerable rate over the forecast time period, owing to the growing prevalence of various chronic diseases, such as cancer, heart diseases, diabetes etc.

Description

The report covers a forecast and an analysis of the injectable drug delivery market on a global and regional level. The study provides historical data for 2017 and 2018 along with a forecast from 2019 to 2025 based revenue (USD Billion). The study includes drivers and restraints of the injectable drug delivery market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the injectable drug delivery market on a global level.

In order to give the users of this report a comprehensive view of the injectable drug delivery market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Injectable Drug Delivery Market1

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new application launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

The study provides a decisive view of the injectable drug delivery market based on type, application, end-user, and region. By type, the global injectable drugs market includes formulation and devices. The formulation segment is sub-segmented into conventional drug delivery (suspensions, solutions, lyophilized formulations, and emulsions), novel drug delivery (long-acting injection formulation, colloidal dispersions, and microparticles), and others. The devices segment includes conventional injection devices and self-injection devices. The self-injection devices segment is further classified into needle-free injectors (NFI), pen injectors, wearable injectors, auto-injectors, and others. The conventional injection devices are segmented into prefilled syringes, fillable syringes, and others. By application, the global injectable drug delivery market is segmented into autoimmune diseases, oncology disorders, hormonal disorders, orphan diseases, and others. By end-user, this global market includes home care, hospital, ambulatory care, physician offices or clinics, and others. By geography, the global injectable drug delivery market includes Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa with its further division into major countries, such as the U.S., Rest of North America, UK, Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of the Middle East and Africa.

Some key players of the global injectable drug delivery market are Baxter International, Nova Nordisk A/S, Becton Dickinson, Sanofi, Pfizer, InjexPharma GmbH, Terumo Corporation, Unilife Corporation, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG., Schott AG, and Eli Lily & Company.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

This report segments the global injectable drug delivery market into:

Global Injectable Drug Delivery Market: Type Analysis

  • Formulation
    • Conventional Drug Delivery
      • Suspensions
      • Solutions
      • Lyophilized Formulations
      • Emulsions
    • Novel Drug Delivery
      • Long Acting Injection Formulation
      • Microparticles
      • Colloidal Dispersions
    • Others
  • Devices
    • Self-Injection Devices
      • Needle-Free Injectors (NFI)
      • Wearable Injectors
      • Pen Injectors
      • Auto-Injectors
      • Others 
    • Conventional Injection Devices
      • Prefilled Syringes
      • Fillable Syringes
      • Others

Global Injectable Drug Delivery Market: Application Analysis

  • Autoimmune Diseases
  • Oncology Disorders
  • Hormonal Disorders
  • Orphan Diseases
  • Others

Global Injectable Drug Delivery Market: End-User Analysis

  • Home Care
  • Hospital
  • Ambulatory Care
  • Physician Offices or Clinics
  • Others

Global Injectable Drug Delivery Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Injectable Drug Delivery Market, 2017-2025 (USD Billion)
    • 2.2. Global Injectable Drug Delivery Market: snapshot
  •  
  • Chapter 3. Injectable Drug Delivery Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global Injectable Drug Delivery Market drivers: impact analysis
      • 3.2.2. Increasing Prevalence of Chronic Diseases
      • 3.2.3. Benefits and Convenience of Using Injections
    • 3.3. Market Restraints
      • 3.3.1. Global Injectable Drug Delivery Market restraints: impact analysis
      • 3.3.2. Injuries and Infections Caused by Needles
      • 3.3.3. Growing Use of Alternative Delivery Methods
    • 3.4. Opportunities
      • 3.4.1. Government Funding and Support
    • 3.5. Porter's Five Forces Analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by type
      • 3.6.2. Market attractiveness analysis, by application
      • 3.6.3. Market attractiveness analysis, by end-user
      • 3.6.4. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Injectable Drug Delivery Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Injectable Drug Delivery Market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Injectable Drug Delivery Market - Product Type Analysis
    • 5.1. Global Injectable Drug Delivery Market: product overview
      • 5.1.1. Global Injectable Drug Delivery Market revenue share, by type, 2018 and 2025
    • 5.2. Formulation
      • 5.2.1. Global Injectable Drug Delivery Market for Formulation, 2017-2025 (USD Billion)
      • 5.2.2. Global Injectable Drug Delivery Market for Conventional Drug Delivery
      • 5.2.3. Global Injectable Drug Delivery Market for Novel Drug Delivery
      • 5.2.4. Global Injectable Drug Delivery Market for Others
    • 5.3. Devices
      • 5.3.1. Global Injectable Drug Delivery Market for Devices, 2017-2025 (USD Billion)
      • 5.3.2. Global Injectable Drug Delivery Market for Self-Injection Devices
      • 5.3.3. Global Injectable Drug Delivery Market for Conventional Injection Devices
  •  
  • Chapter 6. Global Injectable Drug Delivery Market - Application Analysis
    • 6.1. Global Injectable Drug Delivery Market: application overview
      • 6.1.1. Global Injectable Drug Delivery Market revenue share, by application, 2018 and 2025
    • 6.2. Autoimmune Diseases
      • 6.2.1. Global Injectable Drug Delivery Market for Autoimmune Diseases, 2017-2025 (USD Billion)
    • 6.3. Oncology Disorders
      • 6.3.1. Global Injectable Drug Delivery Market for Oncology Disorders, 2017-2025 (USD Billion)
    • 6.4. Hormonal Disorders
      • 6.4.1. Global Injectable Drug Delivery Market for Hormonal Disorders, 2017-2025 (USD Billion)
    • 6.5. Orphan Diseases
      • 6.5.1. Global Injectable Drug Delivery Market for Orphan Diseases,2017-2025 (USD Billion)
    • 6.6. Others
      • 6.6.1. Global Injectable Drug Delivery Market for Others, 2017-2025 (USD Billion)
  •  
  • Chapter 7. Global Injectable Drug Delivery Market - End-User Analysis
    • 7.1. Global Injectable Drug Delivery Market: End-User overview
      • 7.1.1. Global Injectable Drug Delivery Market revenue share, by End-User, 2018 and 2025
    • 7.2. Home Care
      • 7.2.1. Global Injectable Drug Delivery Market for Home Care, 2017-2025 (USD Billion)
    • 7.3. Hospital
      • 7.3.1. Global Injectable Drug Delivery Market for Hospital, 2017-2025 (USD Billion)
    • 7.4. Ambulatory Care
      • 7.4.1. Global Injectable Drug Delivery Market for Ambulatory Care,2017-2025 (USD Billion)
    • 7.5. Physician Offices or Clinics
      • 7.5.1. Global Injectable Drug Delivery Market for Physician Offices or Clinics,2017-2025 (USD Billion)
    • 7.6. Others
      • 7.6.1. Global Injectable Drug Delivery Market for Others,2017-2025 (USD Billion)
  •  
  • Chapter 8. Global Injectable Drug Delivery Market - Regional Analysis
    • 8.1. Global Injectable Drug Delivery Market: regional overview
      • 8.1.1. Global Injectable Drug Delivery Market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
      • 8.2.2. North America Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
      • 8.2.3. North America Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.2.4.2. The U.S. Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.2.4.3. The U.S. Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.2.5.2. Rest of North America Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.2.5.3. Rest of North America Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
      • 8.3.2. Europe Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
      • 8.3.3. Europe Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.3.4. U.K.
        • 8.3.4.1. U.K. Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.3.4.2. U.K. Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.3.4.3. U.K. Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.3.5. Germany
        • 8.3.5.1. Germany Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.3.5.2. Germany Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.3.5.3. Germany Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.3.6.2. France Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.3.6.3. France Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.3.7. Italy
        • 8.3.7.1. Italy Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.3.7.2. Italy Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.3.7.3. Italy Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.3.8. Spain
        • 8.3.8.1. Spain Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.3.8.2. Spain Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.3.8.3. Spain Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.3.9. Rest of Europe
        • 8.3.9.1. Rest of Europe Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.3.9.2. Rest of Europe Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.3.9.3. Rest of Europe Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
      • 8.4.2. Asia Pacific Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
      • 8.4.3. Asia Pacific Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.4.4.2. China Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.4.4.3. China Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.4.5.2. Japan Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.4.5.3. Japan Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.4.6.2. India Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.4.6.3. India Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.4.7. Southeast Asia
        • 8.4.7.1. Southeast Asia Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.4.7.2. Southeast Asia Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.4.7.3. Southeast Asia Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.4.8.2. Rest of Asia Pacific Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.4.8.3. Rest of Asia Pacific Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
      • 8.5.2. Latin America Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
      • 8.5.3. Latin America Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.5.4.2. Brazil Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.5.4.3. Brazil Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.5.5.2. Rest of Latin America Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.5.5.3. Rest of Latin America Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
      • 8.6.2. The Middle East and Africa Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
      • 8.6.3. The Middle East and Africa Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.6.4. GCC Countries
        • 8.6.4.1. GCC Countries Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.6.4.2. GCC Countries Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.6.4.3. GCC Countries Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
      • 8.6.5. Rest of the Middle East and Africa
        • 8.6.5.1. Rest of the Middle East and Africa Injectable Drug Delivery Market revenue, by type, 2017-2025 (USD Billion)
        • 8.6.5.2. Rest of the Middle East and Africa Injectable Drug Delivery Market revenue, by application, 2017-2025 (USD Billion)
        • 8.6.5.3. Rest of the Middle East and Africa Injectable Drug Delivery Market revenue, by End-User, 2017-2025 (USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Baxter International
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Nova Nordisk A/S
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Becton Dickinson
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Sanofi
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Pfizer
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. InjexPharma GmbH
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Terumo Corporation
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Unilife Corporation
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Gerresheimer AG
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Vetter Pharma-Fertigung GmbH & Co. KG.
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments
    • 9.11. Schott AG
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Product portfolio
      • 9.11.4. Business strategy
      • 9.11.5. Recent developments
    • 9.12. Eli Lily & Company
      • 9.12.1. Overview
      • 9.12.2. Financials
      • 9.12.3. Product portfolio
      • 9.12.4. Business strategy
      • 9.12.5. Recent developments

Table Of Figures

List of Figures 

1. Market research process
2. Market research methodology
3. Global Injectable Drug Delivery Market revenue, 2017–2025 (USD Billion) 
4. Porter’s Five Forces Analysis
5. Injectable Drug Delivery Market attractiveness analysis, by type
6. Injectable Drug Delivery Market attractiveness analysis, by application
7. Injectable Drug Delivery Market attractiveness analysis, by end-user
8. Injectable Drug Delivery Market: market attractiveness analysis, by region
9. Company market share analysis, 2017
10. Global Injectable Drug Delivery Market revenue share by type, 2018 and 2025
11. Global Injectable Drug Delivery Market revenue share by Formulation, 2018 and 2025
12. Global Injectable Drug Delivery Market revenue share by Devices, 2018 and 2025
13. Global Injectable Drug Delivery Market revenue share by application, 2018 and 2025
14. Global Injectable Drug Delivery Market revenue share by Autoimmune Diseases, 2018 and 2025
15. Global Injectable Drug Delivery Market revenue share by Oncology Disorders, 2018 and 2025
16. Global Injectable Drug Delivery Market revenue share by Hormonal Disorders, 2018 and 2025
17. Global Injectable Drug Delivery Market revenue share by Orphan Diseases, 2018 and 2025
18. Global Injectable Drug Delivery Market revenue share by Others, 2018 and 2025
19. Global Injectable Drug Delivery Market revenue share by End-User, 2018 and 2025
20. Global Injectable Drug Delivery Market revenue share by Home Care, 2018 and 2025
21. Global Injectable Drug Delivery Market revenue share by Hospital, 2018 and 2025
22. Global Injectable Drug Delivery Market revenue share by Ambulatory Care, 2018 and 2025
23. Global Injectable Drug Delivery Market revenue share by Physicians office or clinics, 2018 and 2025
24. Global Injectable Drug Delivery Market revenue share by Others, 2018 and 2025


Table Of Tables

List of Tables

1. Injectable Drug Delivery Market: market snapshot                                                                                                                       
2. Drivers of Global Injectable Drug Delivery Market: impact analysis 
3. Restraints of Global Injectable Drug Delivery Market: impact analysis  
4. North America Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
5. North America Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
6. North America Injectable Drug Delivery Market revenue, by end-user, 2017–2025 (USD Billion)
7. The U.S. Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
8. The U.S. Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
9. The U.S. Injectable Drug Delivery Market revenue, by end-user, 2017–2025 (USD Billion)
10. Rest of North America Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
11. Rest of North America Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
12. Rest of North America Injectable Drug Delivery Market revenue, by end-user, 2017–2025 (USD Billion)
13. Europe Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
14. Europe Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
15. Europe Injectable Drug Delivery Market revenue, by end-user, 2017–2025 (USD Billion)
16. U.K. Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
17. U.K. Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
18. U.K. Injectable Drug Delivery Market revenue, by end-user, 2017–2025 (USD Billion)
19. Germany Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
20. Germany Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
21. Germany Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
22. France Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
23. France Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
24. Italy Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
25. Italy Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
26. Italy Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
27. Spain Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
28. Spain Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
29. Rest of Europe Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
30. Rest of Europe Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
31. Rest of Europe Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
32. Asia Pacific Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
33. Asia Pacific Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
34. Asia Pacific Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
35. China Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
36. China Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
37. China Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
38. Japan Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
39. Japan Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
40. Japan Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
41. India Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
42. India Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
43. India Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
44. Southeast Asia Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
45. Southeast Asia Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
46. Southeast Asia Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
47. Rest of Asia Pacific Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
48. Rest of Asia Pacific Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
49. Rest of Asia Pacific Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
50. Latin America Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
51. Latin America Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
52. Latin America Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
53. Brazil Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
54. Brazil Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
55. Brazil Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
56. Rest of Latin America Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
57. Rest of Latin America Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
58. Rest of Latin America Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
59. The Middle East and Africa Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
60. The Middle East and Africa Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
61. The Middle East and Africa Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
62. GCC Countries Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
63. GCC Countries Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
64. GCC Countries Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
65. South Africa Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
66. South Africa Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
67. South Africa Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
68. Rest of the Middle East and Africa Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
69. Rest of the Middle East and Africa Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
70. Rest of the Middle East and Africa Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)

Methodology

Free Analysis

Injecting of medicines or drugs directly into patients’ blood via a delivery device is called injectable drug delivery. Some pharmaceutical agents, predominant peptides, proteins, etc. can be administered via injectable routes. The parenteral administration route is one of the most common and efficient drug delivery types. Injectable drug delivery ensures a quick passage of a drug into the body by avoiding first pass metabolism. This drug delivery system also helps in administering drugs in comatose patients. For various medical conditions, such as cystic fibrosis, hormonal imbalance, autoimmune diseases, Wilson’s disease, hepatitis C, ribose-5-phosphate isomerase, and hemophilia, the injectable drug delivery system is preferred mostly.

The global injectable drug delivery market is anticipated to grow at a considerable rate over the forecast time period, owing to the growing prevalence of various chronic diseases, such as cancer, heart diseases, diabetes etc., and technological innovations related to advanced device development in injectable drug delivery systems.

Global Injectable Drug Delivery Market1

The global injectable drug delivery market is fragmented into type, application, and end-user. By type, the global injectable drugs market includes formulation and devices. The formulation segment is sub-segmented into conventional drug delivery (suspensions, solutions, lyophilized formulations, and emulsions), novel drug delivery (long-acting injection formulation, colloidal dispersions, and microparticles), and others. The devices segment includes conventional injection devices and self-injection devices. The self-injection devices segment is further classified into needle-free injectors (NFI), pen injectors, wearable injectors, auto-injectors, and others. The conventional injection devices are segmented into prefilled syringes, fillable syringes, and others. By application, the global injectable drug delivery market is segmented into autoimmune diseases, oncology disorders, hormonal disorders, orphan diseases, and others. By end-user, this global market includes home care, hospital, ambulatory care, physician offices or clinics, and others.

By geography, the global injectable drug delivery market includes Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa. North America held the largest share of the global market in 2017 and is anticipated to remain dominant over the forecast time period as well. In terms of growth rate, the Asia Pacific region is expected to register the highest CAGR over the estimated time period. India and China held the largest shares of the Asia Pacific injectable drug delivery market in 2018.

Some key players of the global injectable drug delivery market are Baxter International, Nova Nordisk A/S, Becton Dickinson, Sanofi, Pfizer, InjexPharma GmbH, Terumo Corporation, Unilife Corporation, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG., Schott AG, and Eli Lily & Company.

Choose License Type

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed